Latent Autoimmune Diabetes of Adults Presenting as Recurrent Diabetic Ketoacidosis

Main Article Content

Shankarappa R S
N Manoj kumar

Abstract

Diabetes mellitus encompasses a spectrum of metabolic disorders characterized by
hyperglycaemia, resulting from genetic and environmental interactions that impair insulin
secretion, glucose utilization, and production. The World Health Organization  revised
its diabetes classification in 2019 to include six categories: Type 1 -insulin-dependent, Type
2 -insulin-resistant, hybrid forms  e.g., Latent Autoimmune Diabetes in Adults -LADA and
ketosis-prone diabetes, other specific types, unclassified diabetes, and hyperglycaemia first
detected during pregnancy. LADA is a hybrid form of diabetes characterized by gradual
autoimmune beta-cell destruction, commonly misdiagnosed as Type 2 diabetes. Diagnostic
criteria include onset after 30 years, islet autoantibodies e.g., GAD, and delayed insulin
dependence. LADA risk factors include low BMI, autoimmune history, and progressive
hyperglycaemia despite oral antidiabetic therapy. High-risk patients undergo GAD antibody
testing for confirmation. Accurate identification of LADA is essential for appropriate
management, as it bridges features of Type 1 and Type 2 diabetes.

Article Details

How to Cite
R S, S. ., & Nallabothula Manoj Kumar. (2024). Latent Autoimmune Diabetes of Adults Presenting as Recurrent Diabetic Ketoacidosis. International Journal of Medical Science and Clinical Research Studies, 4(11), 2105–2107. https://doi.org/10.47191/ijmscrs/v4-i11-39
Section
Articles
Author Biography

N Manoj kumar , Resident, Department of General Medicine, Sri Siddhartha Medical College Hospital and Research Centre, Tumakuru, Karnataka.

  1.  

References

I. Powers AC, Niswender KD, Evans-Molina C. Diabetes Mellitus: Diagnosis, Classification, and Pathophysiology. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL, editors. Harrison’s Principles of Internal Medicine [Internet]. 21st ed. New York, NY: McGraw-Hill Education; 2022 [cited 2024 Apr 8]. Available from: accessmedicine.mhmedical.com/content.aspx?aid=1206999814

II. RSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2022. Int J Diabetes Dev Ctries. 2022 Oct 1; 42(1):1–143.

III. Poudel RR. Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin. Indian Journal of Endocrinology and Metabolism. 2012 Mar; 16(Suppl1):S41.

IV. Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management [Internet]. [Cited 2024 Apr 8]. Available from: https://e-dmj.org/journal/view.php?doi=10.4093/ dmj.2018.0190